[go: up one dir, main page]

CN104894005B - The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide - Google Patents

The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide Download PDF

Info

Publication number
CN104894005B
CN104894005B CN201510217639.XA CN201510217639A CN104894005B CN 104894005 B CN104894005 B CN 104894005B CN 201510217639 A CN201510217639 A CN 201510217639A CN 104894005 B CN104894005 B CN 104894005B
Authority
CN
China
Prior art keywords
exocellular polysaccharide
polysaccharide
bifidobacterium longum
culture
supernatant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510217639.XA
Other languages
Chinese (zh)
Other versions
CN104894005A (en
Inventor
方曙光
马凯
姜甜
夏九学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WeCare Probiotics Co Ltd
Original Assignee
Jiangsu Purplestone Microhealth Biotech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Purplestone Microhealth Biotech Co ltd filed Critical Jiangsu Purplestone Microhealth Biotech Co ltd
Priority to CN201510217639.XA priority Critical patent/CN104894005B/en
Publication of CN104894005A publication Critical patent/CN104894005A/en
Application granted granted Critical
Publication of CN104894005B publication Critical patent/CN104894005B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention belongs to microorganism fields, and in particular to a kind of lactic acid bacteria of high-yield extracellular polysaccharide, the optimum condition and preparation method of extracellular polysaccharide and generated exocellular polysaccharide and application thereof.The present invention provides bifidobacterium longum BL21, BL21 is by cultivating and extracting acquisition exocellular polysaccharide.The exocellular polysaccharide can be used for preparing to improve the external preparation of the colour of skin.Lactic acid bacteria provided by the invention can high yield have inhibit cell in melanin synthesis and reduce the exocellular polysaccharide of skin splash quantity, and since bifidobacterium longum belongs to probiotics, it is completely harmless or even beneficial to human body using the exocellular polysaccharide of its fermenting and producing, security is excellent, can be consequently used for manufacture cosmetics, skin care item and various Dermatologic preparation compositions.

Description

The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide
Technical field
The invention belongs to microorganism fields, and in particular to the lactic acid bacteria BL21 of a kind of high-yield extracellular polysaccharide and produced Exocellular polysaccharide and application thereof.
Background technology
Skin ecto-entad is divided into epidermis and corium two parts, and the depth of the colour of skin depends on melanin in epidermis and (is also referred to as Melanocyte) content number.
Melanin is to be catalyzed using tyrosine as precursor through tyrosine enzyme system, and oxidation polymerization process occurs and is formed one group is answered Miscellaneous pigment composition can be divided into insoluble black 5,6- dihydroxy indole type melanin and soluble higher 5,6- dihydroxy Indole-carboxylic acid type melanin.Melanin is synthesized and moved in the melanosome generated by the melanocyte in basal layer of epidermis It moves on in the keratinocyte of surrounding, constantly moves to skin surface with the update of corneocyte, form the colour of skin, and with angle The update of matter confluent monolayer cells and come off.
Hyperpigmentation in specific region on skin makes the region colour of skin deeper with peripheral region, then forms color spot, often See that color spot species has chloasma, freckle, inflammatory pigmentation etc..Wherein, chloasma is a kind of color for being common in female middle-aged Plain calmness phenomenon, shows as that Face and cheek symmetry sheet is light brown or auburn pigmentation spots, pathogenesis are still endless All clear Chu, current study show that, solarization, sex hormone level are principal elements, skin barrier function imbalance, some drugs, chronic Disease, inherent cause, skin Dysbiosis, contact heavy metal etc. may also cause chloasma occurs.
Make the colour of skin more pale, removal color spot is main work(of the consumer to cosmetics and skin care item to improve the colour of skin uniformity One of energy demand.The common colour of skin, which improves ingredient, includes ascorbic acid and its derivative, licorice (glabridin, Radix Glycyrrhizae Flavones, glycyrrhizic acid etc.), ursin, quinhydrones, kojic acid and its derivative, ferulic acid and its derivatives, tretinoin, azelaic acid class, Tranexamic acid, N-Acetyl-D-glucosamine, niacinamide, the resorcinol class with alkane side chain, 4- methoxysalicylic acids potassium, promotion Organic acid (lactic acid, tartaric acid) that horn cell comes off etc..Above each constituents are different in effect, security.Exploitation tool Have and inhibit that melanin is formed, to reduce color spot, highly safe ingredient all particularly significant to skin care item manufacturer and consumer.
Streptococcus thermophilus (Streptococcus thermophilus) and bifidobacterium longum (Bifidobacterium Longum the lactic acid bacteria of Yoghourt and fermented dairy product production) is commonly used for, it is safe, it is put into Ministry of Public Health's announcement《It can use In the strain list of food》(defend and do supervision hair [2010] 65).Some strains of streptococcus thermophilus and bifidobacterium longum bacterial strain exist Exocellular polysaccharide can be generated in fermentation process.The exocellular polysaccharide that streptococcus thermophilus and bifidobacterium longum generate has on monose and structure There is strain specificity, and influenced by condition of culture;Yield of extracellular polysaccharide is related with bacterial strain and condition of culture.
As a kind of macromolecule polyalcohol, exocellular polysaccharide has certain viscosity and retentiveness, and the property is in Yoghourt Production In there is positive effect, therefore can the streptococcus thermophilus of the extracellular polysaccharide of programmed screening and bifidobacterium longum bacterial strain in conventional industries For Yoghourt Production.
In recent years, the application study on Exopolysaccharides Produced by Lactic Acid Bacteria increasingly increases, and utilizes with generations such as Lactococcus lactis Method (Japanese Unexamined Patent Publication 9-249524 publications, the Japanese Unexamined Patent Publication 10- that phosphorylated polysaccharide is utilized as moisturizer and whitening agent No. 251140 publications), method (the Japanese Unexamined Patent Publication 7- that the polysaccharide component generated using lactobacillus strains is utilized as antiphlogistic No. 70209 publications), contain method (CN 101505721A) of the lactic acid bacteria culture supernatant as wrinkle inhibitor of exocellular polysaccharide; But there has been no the reports for using bifidobacterium longum and the exocellular polysaccharide of streptococcus thermophilus generation as colour of skin improvement ingredient.
The content of the invention
It is an object of the invention to provide it is a kind of can high-yield extracellular polysaccharide lactic acid bacteria and generated exocellular polysaccharide and its Purposes.The exocellular polysaccharide can inhibit the synthesis of melanin, play an important role of to improve the colour of skin.
Technical scheme is as follows:
A kind of lactic acid bacteria of high-yield extracellular polysaccharide, entitled BL21 belong to bifidobacterium longum (Bifidobacterium Longum), China Committee for Culture Collection of Microorganisms's common micro-organisms center is preserved in, address is Chaoyang District, Beijing City north The institute 3 of occasion West Road 1, deposit number are CGMCC No.10452, and preservation date is on January 27th, 2015.
The present invention also provides a kind of exocellular polysaccharides produced by above-mentioned lactobacillus-fermented.
The present invention also provides a kind of methods that above-mentioned lactobacillus-fermented produces the exocellular polysaccharide, comprise the steps of: (1) by BL21 inoculations in being carried out in culture medium, cultivation temperature is 20~50 DEG C, incubation time for 1~60 it is small when, trained Nutrient solution;(2) exocellular polysaccharide is extracted from the culture solution.
Further, the culture medium includes following components in percentage by weight:0.5% fructose, 1.2% sucrose, The water of 0.5% oligofructose, 0.5% galactooligosaccharide and surplus.
Further, in the step 1), incubation specifically, during prior to 37-45 DEG C quiescent culture 12-14 small, then It is cooled to 20-35 DEG C, when culture 36-48 is small.
Further, the step (2) comprises the following steps:A, using the method for press filtration or centrifugation from the culture solution In isolate the first supernatant;B, the chloroform or trichloroacetic acid of its volume 1/10~1/5 are incorporated as in first supernatant, Centrifugation or stratification and the second supernatant is extracted after mixing, the step b can be repeated as many times as desired;C, step b is obtained Second supernatant be mixed and stirred for being not less than 85% ethanol water for the concentration of 1~3 times of its volume, filtering Separation obtains precipitate;D, the precipitate is carried out with ethanol water eluting repeatedly and dry, obtains exocellular polysaccharide.
Further, in the step b, before chloroform or trichloroacetic acid is added in, the dissolved weight that sterilizes first is added in Content is the aqueous solution of 0.2% carragheen, and additive amount is the 2-2.1% of the first supernatant weight.
Further, the drying temperature in the step d is 50~80 DEG C, when drying time is 1~24 small.
The present invention also provides the external preparation containing above-mentioned exocellular polysaccharide, the external preparation is used to improve the colour of skin.
Further, the external preparation is toner, lotion, cream, facial mask, Essence, foundation cream, foundation emulsion, the screening flaw Frost, suncream or externally applied drug.
It, can also be according to normal in addition to addition exocellular polysaccharide is as active ingredient when preparing preparation for external application to skin and skin care item Rule add in grease, surfactant, polyalcohols, moisturizer, antifoaming agent, thickener, preservative, antioxidant, acid-base accommodation Agent, essence and flavoring agent, pigment, ultra-violet absorber, all kinds of functional components, powder, water etc..The manufacturing process that can be taken is conventional The manufacturing process of cosmetics, skin care item or external application pharmaceuticals.
Further, content of the exocellular polysaccharide in the external preparation is 0.1~99.9%.
Further, content of the exocellular polysaccharide in the external preparation is 0.1~5%.
Lactic acid bacteria provided by the invention can high yield have inhibit cell in melanin synthesis and reduce skin splash quantity Exocellular polysaccharide, and since bifidobacterium longum belongs to probiotics, using its fermenting and producing exocellular polysaccharide to human body entirely without Harmful or even beneficial, security is excellent, can be consequently used for manufacture cosmetics, skin care item and various Dermatologic preparation compositions.
Description of the drawings
Fig. 1 is to produce melanin situation, Fig. 1 a for the B16 cells of embodiment 3:Control group, Fig. 1 b:Exocellular polysaccharide group (3.3mg/ml);
Fig. 2 is the influence that various concentration exocellular polysaccharide forms B16 cell viabilities and melanin.
Specific embodiment
With reference to embodiment, the present invention is further described, and following embodiments are illustrative, be not it is limited, Protection scope of the present invention cannot be limited with following embodiments.
Embodiment 1:Separation, the screening and identification of bacterial strain
Healthy infants fecal specimens are acquired, with sterile water dissolution, gradient dilution is added in the tablet of sterilizing, is inclined Enter into 55 DEG C or so of MRS culture mediums, MRS culture medium prescriptions are:Peptone 10.0g, beef extract 8.0g, yeast extract 4.0g, Lactose 20.0g, dipotassium hydrogen phosphate 2.0g, sodium acetate 5.0g, magnesium sulfate 0.2g, manganese sulfate 0.05g, L-cysteine hydrochloride 1.0g, Triammonium citrate 2.0g, Tween 80 1.0g, agar 20.0g between pH6.0~6.5, add distilled water to 1000mL, and 121 DEG C sterilizing 20min.Under anaerobic, 37 DEG C of culture 72h.It selects the big energetic bacterium colony of molten calcium circle and carries out line purifying training It supports, is further inoculated into 1%~3% volume ratio in the cow's milk of 10% (W/V) solid content, when 43 DEG C of quiescent cultures 6 are small, stirring Curdled milk and observation state.
Selecting curdled milk has wire drawing phenomenon, the bacterial strain of curdled milk appearance exquisiteness, and such bacterial strain is mostly that exocellular polysaccharide yield is higher Bacterial strain.Curdled milk does not generate exocellular polysaccharide or exocellular polysaccharide yield is very low into particle appearance, fineless and smooth bacterial strain.
One plant be isolated to is named as BL21, and the observation under the microscope of the bacterial strain is in wooden club shape, and tapered shape is short Small, more carefully, energy lactose fermenters, glucose etc. generate lactic acid and acetic acid, a kind of Gram-positive bacillus of anaerobism.It simultaneously should Bacterium 16S rDNA sequences are compared with type strain, are accredited as bifidobacterium longum, are named as bifidobacterium longum BL21 (Bifidobacterium longum BL21), is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms The heart, deposit number are CGMCC No.10452, and preservation date is on January 27th, 2015.
Embodiment 2:Fermentation and Polyose extraction
The bifidobacterium longum BL21 for screening gained is inoculated into exocellular polysaccharide culture medium, each group in exocellular polysaccharide culture medium Divide weight percent:0.5% fructose, 1.2% sucrose, 0.5% oligofructose, 0.5% galactooligosaccharide as carbon source and The water of surplus, prior to 37 DEG C at quiescent culture 12 it is small when, then reduce temperature to 30 DEG C culture 36 it is small when.
Culture solution is handled using angle rotor centrifuge, and 6000rpm is centrifuged 20 minutes, collects the first supernatant.Then to Add in the OK a karaoke club glue solution of the first supernatant weight 2% in one supernatant, the OK a karaoke club glue solution be it is sterilized after card Glue is drawn to be dissolved in the water acquisitions, wherein carragheen content is 0.2wt%, after abundant mixing, adds in the chloroform of 1/10 volume, shakes Make 6000rpm centrifugations 15 minutes after mixing, make its layering, liquid is divided into 3 layers, and upper strata is the second supernatant, and middle level is analysis The protein layer gone out, bottom are chloroform.
The second supernatant is collected, adds in 95% alcohol of 2 times of volumes, stirring, exocellular polysaccharide is in cotton-shaped precipitation, with 200 mesh Net filtration is collected.
By the exocellular polysaccharide of collection be placed in 80% alcoholic solution of 1 times of volume impregnate 4 it is small when, take out and squeeze remove wine Essence when being placed on that drying process 4 is small in 60 DEG C of baking ovens, obtains block-like exocellular polysaccharide.It is used to test after being crushed with mortar.
Bifidobacterium longum BL21 Exopolysaccharide Production From The Fermentation liquid polysaccharide concentrations are up to 5%.
Embodiment 3:The influence that bifidobacterium longum BL21 exocellular polysaccharides form B16 cells melanin
With the DMEM culture solution culture B16 melanoma cells containing 5% hyclone, condition of culture is 37 DEG C, 5%CO2It is permanent Temperature culture.It takes the logarithm the B16 melanoma cells of phase, discards culture solution, cleaned 2 times with PBS liquid, add in culture solution piping and druming, adjust Concentration of cell suspension is 5 × 104-10 × 104/ml, is added in 96 orifice plates, and 100 μ l are added in per hole.Culture 12-16 makes when small Cell attachment sucks culture solution.
The exocellular polysaccharide that embodiment 2 obtains is configured to the culture solution of various concentration, while adds in the CCK-8 reagents of 10 μ l (CCK-8Cel l Counting Kit, Yeasen) and the method test cell vigor indicated according to kit.Control group is set (cell+culture solution), each concentration group of exocellular polysaccharide set 5 multiple holes.
Cultivate 56 it is small when after, digested with 0.25% pancreatin, supernatant abandoned with 500rpm centrifugations 5min, under each processing factor Cell add in 200ul contain 10% dimethyl sulfoxide (DMSO) NaOH (1mol/L) solution, be completely dissolved black when 65 DEG C of water-baths 2 are small Crude granule, absorbance A value at spectrophotometer measurement 490nm.Melanin formation rate=A experimental groups/A control group × 100%.
Result of the test shows that it is thin that the exocellular polysaccharide that bifidobacterium longum BL21 is generated can substantially reduce B16 under certain concentration The formation of born of the same parents' melanin, such as it can reduce melanin formation rate up to 50% under 3.3mg/ml concentration.
The photo of B16 cells production melanin situation is shown in attached drawing 1.Cell viability and melanin production statistical chart are shown in attached drawing 2.
Embodiment 4:The preparation of lotion
The exocellular polysaccharide according to the form below 1 that bifidobacterium longum BL21 bacterial strains generate is formulated as lotion.
Table 1
Collocation method is:After whole raw materials are mixed in a reservoir, to 70 DEG C, 300rpm is stirred 40 minutes heating water bath. During for human test, lotion used in blank control group is added without exocellular polysaccharide.
Embodiment 5:Human test
Volunteer is women of 40 ages at 35-52 Sui.Test group, control group, each 20.
Using the lotion prepared in embodiment 4, the exocellular polysaccharide containing 1%W/W in lotion used in test group, used in control group Exocellular polysaccharide is free of in lotion.
Before the test begins facial given zone is obtained using VISIA Complexion Analys is face analysis system Color spot, chloasma quantity in domain obtain the melanin numerical value of skin of face using 580 skinanalysis apparatus of Cutometer MPA.
Volunteer uses lotion respectively once, to be measured using after 8 weeks to color spot quantity and melanin numerical value sooner or later daily. Statistical result shows that exocellular polysaccharide can substantially reduce color spot, chloasma quantity, reduces dermal melanin numerical value, and concrete outcome is shown in The following table 2:
Table 2

Claims (2)

1. a kind of lactic acid bacteria of extracellular polysaccharide, which is characterized in that entitled BL21 belongs to bifidobacterium longum (Bifidobacterium longum), is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, protects It is CGMCC No.10452 to hide number, and preservation date is on January 27th, 2015.
2. a kind of method that bifidobacterium longum BL21 as described in claim 1 prepares exocellular polysaccharide, which is characterized in that comprising following Step:Bifidobacterium longum BL21 described in claim 1 is inoculated into exocellular polysaccharide culture medium, each group in exocellular polysaccharide culture medium Divide weight percent:0.5% fructose, 1.2% sucrose, 0.5% oligofructose, the water of 0.5% galactooligosaccharide and surplus, When quiescent culture 12 is small at prior to 37 DEG C, then reduce temperature to 30 DEG C culture 36 it is small when;
Above-mentioned culture solution is handled using angle rotor centrifuge, and 6000rpm is centrifuged 20 minutes, collects the first supernatant, then to the Add in the OK a karaoke club glue solution of the first supernatant weight 2% in one supernatant, the OK a karaoke club glue solution be it is sterilized after card Glue is drawn to be dissolved in the water acquisitions, wherein carragheen content is 0.2wt%, after abundant mixing, adds in the chloroform of 1/10 volume, shakes Make 6000rpm centrifugations 15 minutes after mixing, make its layering, liquid is divided into 3 layers, and upper strata is the second supernatant, and middle level is analysis The protein layer gone out, bottom are chloroform;
The second supernatant is collected, adds in 95% alcohol of 2 times of volumes, stirring, exocellular polysaccharide is in cotton-shaped precipitation, with 200 mesh net mistakes Filter is collected;
By the exocellular polysaccharide of collection be placed in 80% alcoholic solution of 1 times of volume impregnate 4 it is small when, take out and squeeze remove alcohol, put When putting that drying process 4 is small in 60 DEG C of baking ovens, block-like exocellular polysaccharide is obtained.
CN201510217639.XA 2015-04-30 2015-04-30 The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide Active CN104894005B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510217639.XA CN104894005B (en) 2015-04-30 2015-04-30 The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510217639.XA CN104894005B (en) 2015-04-30 2015-04-30 The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide

Publications (2)

Publication Number Publication Date
CN104894005A CN104894005A (en) 2015-09-09
CN104894005B true CN104894005B (en) 2018-05-22

Family

ID=54026966

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510217639.XA Active CN104894005B (en) 2015-04-30 2015-04-30 The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide

Country Status (1)

Country Link
CN (1) CN104894005B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106399163B (en) * 2016-09-08 2019-09-27 江苏微康生物科技有限公司 A kind of anti-aging probiotics preparation and preparation method
CN106399192A (en) * 2016-10-25 2017-02-15 江苏微康生物科技有限公司 Lactic acid bacterium fermented lysate as well as preparation method and application thereof
CN107603919A (en) * 2017-11-01 2018-01-19 江苏微康生物科技有限公司 A kind of heat resistant type bifidobacterium longum and its screening technique and bacterium powder preparation method
CN108186535A (en) * 2018-03-12 2018-06-22 黑龙江军门现代农业发展有限公司 A kind of brown sugar silk mask
CN111621461B (en) * 2020-05-28 2022-10-11 武汉微康益生菌研究院有限公司 Method for improving activity and tolerance of bacillus coagulans BC99 and application thereof
CN116478857B (en) * 2023-02-10 2023-12-15 宁波希诺亚海洋生物科技有限公司 A polysaccharide-producing Bifidobacterium longum variant and its polysaccharide application in crystal ball probiotic preparations
CN116585360B (en) * 2023-05-24 2023-11-14 微康益生菌(苏州)股份有限公司 Probiotic agent for improving chronic kidney disease and application thereof
CN117987333B (en) * 2024-04-07 2024-06-07 微康益生菌(苏州)股份有限公司 Composite probiotics for relieving sports fatigue and application thereof
CN118272282B (en) * 2024-06-04 2024-10-11 微康益生菌(苏州)股份有限公司 Probiotics containing bifidobacterium longum BL21 strain for promoting development and growth and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003916A1 (en) * 2008-07-11 2010-01-14 Chr. Hansen A/S New probiotic bifidobacterium longum
WO2010055499A2 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
WO2012069546A1 (en) * 2010-11-23 2012-05-31 Chr. Hansen A/S Use of glycosidase in preparation of a milk product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05331036A (en) * 1992-05-28 1993-12-14 Yakult Honsha Co Ltd Melanism inhibitor and cosmetic containing the same
JP4054730B2 (en) * 2003-07-11 2008-03-05 株式会社ファンケル α-Glucosidase activator
JP2006087345A (en) * 2004-09-24 2006-04-06 Toyo Shinyaku:Kk Fermented product obtained from eggplant
TW201309339A (en) * 2011-08-26 2013-03-01 Tsong-Min Chang Whitening the skin with products obtained from liquid culture of Bifidobacterium spp.
KR101440469B1 (en) * 2012-07-27 2014-09-17 강원대학교산학협력단 Method of fermented wild ginseng root using complex strains and cosmetic composition comprising thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003916A1 (en) * 2008-07-11 2010-01-14 Chr. Hansen A/S New probiotic bifidobacterium longum
WO2010055499A2 (en) * 2008-11-11 2010-05-20 Alimentary Health Limited Bifidobacterium longum
WO2012069546A1 (en) * 2010-11-23 2012-05-31 Chr. Hansen A/S Use of glycosidase in preparation of a milk product

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
一种双歧杆菌胞外多糖免疫调节功能研究;李伟欣;《微生物学通报》;20091231;第36卷(第6期);931-935 *
双歧杆菌22-5胞外多糖(EPS)的分离、纯化及纯度鉴定;欧阳清波 等;《食品与发酵工业》;20051231;第31卷(第6期);127-130 *

Also Published As

Publication number Publication date
CN104894005A (en) 2015-09-09

Similar Documents

Publication Publication Date Title
CN104894005B (en) The lactic acid bacteria BL21 and preparation method and application of a kind of high-yield extracellular polysaccharide
CN115105452B (en) Black tea fermentation filtrate and preparation method and application thereof
KR101388918B1 (en) Lactobacillus rhamnosus HK-9 derived from human body, and fermented material and cosmetic composition using it
CN115554226B (en) Multi-strain fermentation filtrate and preparation method and application thereof
CN112920983A (en) Lactobacillus plantarum capable of improving facial sensitive skin and repairing skin barrier
CN113604395B (en) Lactobacillus plantarum capable of fermenting dendrobium nobile and improving skin quality by fermentation liquor thereof
CN111534455B (en) Preparation of lactobacillus sporolysis product and application of lactobacillus sporolysis product in cosmetics
CN114632055A (en) Whitening and relieving plant fermentation product and preparation method and application thereof
CN105296541A (en) Oat fermentation liquor, preparation method thereof and application of oat fermentation liquor as cosmetic raw material
KR20160141205A (en) The novel strain Lactobacillus sp cosmetic composition containing the culture medium as an active ingredient
CN104706567A (en) Method for extracting pearl fetal sac liquid from pearl fetal sac of mother pearl shellfish and product thereby
CN107137628A (en) Hyaluronidase inhibitor derived from symbiotic fermentation product and application thereof
CN108042456B (en) Preparation method and application of dendrobium officinale fermentation product
CN113842341B (en) Roselle fermentation product and preparation method and application thereof
CN109169899A (en) A kind of preparation method of the shield stomach acidified milk containing Hericium erinaceus beta glucan
KR101194226B1 (en) Cosmetic composition for antioxidant and whitening effects having fermented paprika extract and manufacturing method thereof
CN114262675A (en) Preparation of composite bacteria fermentation filtrate and application of whitening effect of composite bacteria fermentation filtrate in cosmetics
TWI701033B (en) Bundling energy enhancer of collagen fiber
JP6475475B2 (en) Collagen production promoter
CN115093985A (en) Bifidobacterium lactis and fermentation method and application thereof
CN111349678A (en) Extraction method of rape pollen polysaccharide and extraction product
CN111544352B (en) Tremella-ganoderma lucidum composite fermentation product, cosmetic composition with anti-aging effect and preparation method and application thereof
JP2004149442A (en) Cosmetic
CN116536368B (en) Bacillus marinus fermentation product, preparation method and application thereof
CN111789778A (en) Face cream containing rose fermentation liquor and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 215200 Longqiao Road 1033, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province

Patentee after: JIANGSU WECARE BIOTECHNOLOGY CO., LTD.

Address before: 215200 Dragon Bridge Road, Wujiang District, Suzhou, Jiangsu Province, No. 1033

Patentee before: JIANGSU ZISHI WEIKANG BIOTECHNOLOGY CO., LTD.

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 215200 Longqiao Road 1033, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province

Patentee after: Weikang probiotics (Suzhou) Co.,Ltd.

Address before: 215200 Longqiao Road 1033, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province

Patentee before: JIANGSU WECARE BIOTECHNOLOGY Co.,Ltd.